Akoustis Technologies

Aktis Oncology develops precision alpha‑emitting radiopharmaceuticals for solid tumors, combining theranostics and just‑in‑time logistics to deliver targeted cancer therapy with minimal healthy tissue exposure.

Headquarters: United States (USA)

Akoustis Technologies Logo
Company Profile
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
AKTS Akoustis Technologies
Cap: 0.0B
EQUITY NCM USD US00973N1028 Active
📈
Home Login